- Research article
- Open Access
Involvement of the different lung compartments in the pathogenesis of pH1N1 influenza virus infection in ferrets
© The Author(s) 2016
- Received: 19 April 2016
- Accepted: 10 October 2016
- Published: 8 November 2016
Severe cases after pH1N1 infection are consequence of interstitial pneumonia triggered by alveolar viral replication and an exacerbated host immune response, characterized by the up-regulation of pro-inflammatory cytokines and the influx of inflammatory leukocytes to the lungs. Different lung cell populations have been suggested as culprits in the unregulated innate immune responses observed in these cases. This study aims to clarify this question by studying the different induction of innate immune molecules by the distinct lung anatomic compartments (vascular, alveolar and bronchiolar) of ferrets intratracheally infected with a human pH1N1 viral isolate, by means of laser microdissection techniques. The obtained results were then analysed in relation to viral quantification in the different anatomic areas and the histopathological lesions observed. More severe lung lesions were observed at 24 h post infection (hpi) correlating with viral antigen detection in bronchiolar and alveolar epithelial cells. However, high levels of viral RNA were detected in all anatomic compartments throughout infection. Bronchiolar areas were the first source of IFN-α and most pro-inflammatory cytokines, through the activation of RIG-I. In contrast, vascular areas contributed with the highest induction of CCL2 and other pro-inflammatory cytokines, through the activation of TLR3.
- Alveolar Epithelial Cell
- Diffuse Alveolar Damage
- Vascular Area
- Alveolar Area
In 2009, the swine-origin H1N1 influenza A virus (IAV) emerged and caused outbreaks of respiratory illness in humans around the world. After the 2009 pandemic, outbreaks of that strain have continued to cause serious illness and increased mortality, particularly in young adults and children . The physiopathology of pandemic H1N1 (pH1N1) infection differs between individuals. Whilst most patients develop mild upper respiratory-tract infection , some patients progress to develop severe lower respiratory tract complications . In addition, high rates of clinically unapparent infections have been reported by seroepidemiological studies [4, 5]. This evidence suggests that the severity of influenza is, at least, partially determined by host factors.
Severe cases after pH1N1 infection are consequence of diffuse alveolar damage (DAD) , also termed interstitial pneumonia, triggered by the spread of pH1N1 infection from the upper to the lower respiratory tract [6, 7] and an exacerbated inflammatory host immune response [8–12]. Several hypotheses have been made about the mechanisms involved in the dysregulation of the host inflammatory response after pH1N1 and IAV infection. However, all of them involve the up-regulation of pro-inflammatory cytokines [13, 14] and the influx of inflammatory leukocytes to the lungs [9, 15].
While leukocytes have traditionally been considered the major source of pro-inflammatory cytokines, there is also a consensus calling attention to the role of epithelial and endothelial cells as important sources of pro-inflammatory cytokines during various infectious processes [16–18]. In a recent study, Brandes et al.  showed that lethality in a murine model of acute influenza arose directly from the damage caused by constrained innate inflammation primarily involving neutrophils co-acting with monocytes. However, the first influx of neutrophiles and monocytes needs to be induced by the release of innate immune mediators from lung resident cell populations (respiratory epithelium, endothelium and alveolar macrophages), which first come in contact with the virus.
During pH1N1 infection, leukocyte influx into the lungs is regulated by the signalling effects of cytokines and chemokines released by different lung cell populations in response to infection [13, 14, 19]. Although cytokines have specific functions and are released in a cell-type-dependent manner, all of them are produced/activated via common mechanisms involving the activation of pattern recognition receptors (PRRs) [20, 21]. By these means, several studies have implicated either lung endothelial or epithelial cells as key regulators in the initial release of pro-inflammatory cytokines after pH1N1 infection [10, 14, 16]. However, their relative contribution to cytokine release regulation mechanisms and the dynamics of their release have not entirely been elucidated.
Understanding which cellular types and inflammatory dynamics are involved in the development of the detrimental inflammatory response after IAV infection, is important for the future development of therapeutic strategies, designed to the control of the host immune response. In this way, the modulation of the host immune response will have the potential advantage of exerting less selective pressure on viral populations, an important factor in the development of IAV infection therapies. With the aim to unravel the mechanisms involved in the regulation of the innate immune response against IAV infection, and the relative contribution of the different lung compartments, we investigated the early induction of innate immune molecules, observed in different lung compartments. We tried to discern the cytokine production of the main cell type present in each lung compartment (endothelial cells, epithelial bronchiolar cells and alveolar epithelial cells) by means of a laser capture microdissection (LCM) technique. As the limitations of the technique did not allow us to completely individualize the target cells, we assessed the cytokine expression associated to the viral replication in the different lung compartments (vascular, alveolar and bronchiolar).
The human pH1N1 isolate A/CastillaLaMancha/RR5911/2009 was used in the present study. The virus was isolated at the National Influenza Centre, Centro Nacional de Microbiología, Instituto de Salud Carlos III (CNM, ISCIII) from a respiratory sample sent by the Spanish Influenza Surveillance System for virological characterization. It was isolated from a 35-years old woman, without co-morbidities, who developed a severe disease and died. The viral isolate was passaged in Madin-Darby Canine kidney (MDCK) cell cultures four times and had a final titre of 106.02 TCID50/mL. Titre was determined using the Reed and Muench method .
Eleven neutered male ferrets between 8 and 9 months of age, and seronegative for IAV (influenza A antibody competition multi-species ELISA, ID Screen®, France), were randomly selected from a stable, purposely bred colony (Euroferret, Denmark). Upon arrival at the Centre de Recerca en Sanitat Animal (CReSA), the animals were placed in biosafety level 3 (BSL-3) facilities. Ferrets were randomly assigned to different experimental groups, separated into experimental isolation rooms and then acclimated during 1 week. The animals were inhabited in standard housing cages for laboratory ferrets (F-SUITE Ferret Housing, Tecniplast, Italy) and they were provided with commercial food pellets and tap water ad libitum throughout the experiment. All experiments were performed under a protocol (no. 1976) that was reviewed and approved by the Animal and Human Experimentation Ethics Commission of the Universitat Autònoma de Barcelona. Animals were divided into two groups. The control group included two ferrets and the infected group included nine ferrets which were intratracheally inoculated with 105 TCID50/mL of the A/CastillaLaMancha/RR5911/2009 virus diluted in 0.5 mL of phosphate buffer saline (PBS). During inoculation, animals were deep sedated with butorphanol (0.05 mg/kg) (Torbugesic® Vet, S.A., Spain) and medetomidine (0.05 mg/kg) (Domtor® Pfizer, S.A., Spain) administered subcutaneously. After inoculation, animals were reverted from sedation with atipamezole (0.25 mg/kg) subcutaneously administered and monitored by a specialized veterinarian until complete recovering from sedation. Control and infected animals were euthanized at 0 and 12, 24 and 72 h post infection (hpi) respectively. Early times post infection were selected in order to evaluate the innate immune response and assess early immune viral recognition and induction of pro-inflammatory cytokines and chemokines throughout infection. Animals were euthanized by an intravenous injection of sodium pentobarbital (100 mg/kg), under anaesthesia with ketamine (5–10 mg/kg) (Imalgene 1000® Merial, S.A., Spain) and medetomidine (0.05 mg/kg) (Domtor® Pfizer, S.A., Spain), administered subcutaneously. Necropsies were performed in control and infected animals after euthanasia according to a standard protocol.
Right lung lobe sections (cranial and caudal lobes), were taken for histological examination. The tissues were fixed for 24–48 h in neutral-buffered 10% formalin, and then embedded in paraffin wax in two different blocs containing one portion of the cranial and the caudal right lung lobes, consecutively taken. One of the paraffin blocks was sectioned at 3 µm, and stained with haematoxylin and eosin (HE) for examination under light microscopy; the second paraffin block was used for microdissection studies.
Cross sections of the cranial and caudal pulmonary lobes for each animal were histopathologically and separately evaluated. Semiquantitative assessment of IAV-associated microscopic lesions in the lungs was performed. The lesional scoring was graded on the basis of lesion severity as follows: grade 0 (no histopathological lesions observed), grade 1 (mild to moderate necrotizing bronchiolitis), grade 2 (bronchointerstitial pneumonia characterised by necrotizing bronchiolitis and alveolar damage in adjacent alveoli), and grade 3 (necrotizing bronchiolitis and diffuse alveolar damage in the majority of the pulmonary parenchyma). Microscopic lesional scores were assigned for each lobe, and the means of the two lobes were used for the final histopathological score for each animal.
Laser capture microdissection
Lung samples from infected and control animals were used for the microdissection study. For each animal, 20 μm sections were cut from formalin-fixed paraffin-embedded (FFPE) lung tissue and mounted in PEN-membrane slides (two sections per slide). Prior to deparaffinization, slides were placed into an oven at 60 °C for 25 min. For each lung sample, sections were cut, deparaffinised, and rehydrated using standard protocols with RNase-free reagents, and stained with 1% cresyl violet acetate (SIGMA, C5042), and alcoholic 1% eosin (Alvarez, 10-3051). Stained slides were then dehydrated through a series of graded ethanol steps prepared with DEPC treated water (Ambion, P/N AM9915G) to 100% ethanol. The slides were then air-dried for 10 min, and individually frozen at −80 °C in 50 mL parafilm sealed falcons, before being transferred to the LCM microscope (LMD6500; Leica Microsystems) for simple microdissection.
The different dissected areas were then collected separately into RNAse-free 1.5 mL PCR tubes, per lung compartment.
Viral detection and quantification
Viral titration from lungs samples and nasal swabs was performed on control and infected animals, and determined by plaque forming units (PFU) as described previously . A portion of around 0.2 g of the right caudal lung lobe and nasal swabs were placed in 0.5 mL of Dulbecco’s Modified Eagle’s Medium (DMEM) (BioWhittaker®, Lonza, Verviers, Belgium) with 600 µg/mL penicillin and streptomycin, and frozen at −80 °C until further processing.
For the detection of IAV antigen by immunohistochemistry (IHC), paraffin sections were stained with a primary antibody against the influenza A nucleoprotein (NP), as previously described [8, 24]. Briefly, an antigen retrieval step was performed using protease XIV (Sigma-Aldrich, USA) for 10 min at 37 °C, and then blocked for 1 h with 2% bovine serum albumin (BSA) (85040C, Sigma-Aldrich Química, S.A., Spain) at room temperature (RT). Samples were then incubated with a commercially available mouse-derived monoclonal antibody (ATCC, HB-65, H16L-10-4R5) concentration (343 mg/mL), as a primary antibody, at a dilution of 1:100 at 4 °C overnight, followed by 1 h incubation with biotinylated goat antimouse IgG secondary antibody (Dako, immunoglobulins As, Denmark). Finally, an ABC system (Thermo Fisher Scientific, Rockjord, IL, USA) was used and the antigen–antibody reaction was visualized with 3, 3′-diaminobenzidine DAB as chromogen. Sections were counterstained with Mayer’s haematoxylin. The positive control consisted of a FFPE lung from a ferret and of a FFPE heart from a chicken, experimentally infected with influenza. The same sections in which the specific primary antibody was substituted with PBS or an irrelevant antibody [anti-Porcine Circovirus type 2 (PCV2), diluted 1:1000] were used as negative controls. Semiquantitative assessments of IAV antigen expression in the lungs were performed. The positive cells in six arbitrarily chosen 20× objective fields in alveolar areas, and five arbitrarily chosen 20× objective fields in bronchial or bronchiolar areas, were quantified separately in each lung lobe (cranial and caudal) for every animal. The mean of the total cell counts per field across two lobes was calculated for each animal.
Viral RNA from total lung samples (proximal mediastinic right caudal lobe section of 5 mm2) was extracted with NucleoSpin® RNA Virus Kit (Macherey–Nagel, Düren, Germany), following the manufacturer’s instructions. IAV matrix (M) gene was then quantified from the RNA extracted by the Taq-Man one-step quantitative real time PCR (RRT-PCR) using the primers and probe described in Additional file 1 . One-step RRT-PCR master mix reagents (Applied Biosystems, Foster City, CA, USA) were used following the manufacturer’s instructions using 5 μL of eluted RNA in a total volume of 25 μL. The amplification conditions were as follows: reverse transcription at 48 °C for 30 min; initial denaturation reaction at 95 °C for 15 min and 40 PCR-cycles of 95 °C 15 s, and 60 °C 1 min. Reaction was performed using Fast7500 equipment (Applied Biosystems). Samples with a Ct value ≤40 were considered positive for influenza viral RNA detection.
Viral RNA detection from different lung anatomic compartments was extracted using the miRNeasy FFPE Kit (no. 217504, Qiagen, Valencia, CA, USA) and the RNA stabilisation and on-column DNase digestion protocols (Qiagen), following the manufacturer’s instructions. Briefly, the transfer film with the attached dissected material, per animal and lung compartment, was placed in deparaffinization melting buffer at 72 °C for 10 min, and then treated with Proteinase K at 60 °C for 45 min. Isolated RNA was concentrated using ethanol precipitation method and membrane column attachment. RNA was eluted twice in 14 μL total DEPC water, yielding between approximately 5 and 9 ng/μL of RNA, per sample. RNA extracts were stored at −80 °C until required. Reverse transcription was performed using an ImProm-II reverse transcription system, with random primers (Promega, Madison, WI, USA), using 10 µL of the eluted RNA. IAV M gene was then quantified on the RNA, extracted by two-step RRT-PCR using the forward and reverse primers for detection of the M gene, described in Additional file 1. Briefly, RRT-PCR was performed using a Power SYBR green kit, (Applied Biosystems) and Fast 7500 equipment (Applied Biosystems). PCR reactions were performed in 10 μL reaction volumes, in quadruplicates; 45 amplification cycles were used, and the annealing temperature was 60 °C. Results are expressed as inverted Ct values. Samples with a Ct value ≤45 were considered positive for influenza viral RNA detection.
Gene expression profiles
Total RNA was isolated from LCM tissues, using the miRNeasy FFPE Kit (no. 217504, Qiagen), as described in the above section.
Relative mRNA expression levels of IFNα, IL-6, TLR-3, IL-8, RIG-I, IFNγ, TNFα, CCL2, CCL3 and the housekeeping gene β-actin, at each different lung compartment, were assessed by two-step RRT-PCR. Primer sequences and source are illustrated in the Additional file 1. Amplicon sizes of the target genes range between 90 and 120 base pairs. Briefly, RRT-PCR was performed using a Power SYBR green kit (Applied Biosystems) and Fast 7500 equipment (Applied Biosystems). RNA extraction was performed on the ferret lung tissue samples with an RNeasy Mini Kit (Qiagen), using the RNA stabilization and on-column DNase digestion protocols (Qiagen). Reverse transcription was performed using an ImProm-II reverse transcription system (Promega, Madison, WI, USA), at 0.5 µg RNA. PCR reactions were performed in 10 µL reaction volumes in quadruplicates; 45 amplification cycles were used, and the annealing temperature was 60 °C. The expression levels were normalized using the house-keeping gene β-actin using the relative standard curve method and taking into account primer efficiency. The results are expressed as arbitrary units.
Vascular gene expression
Relative mRNA expression levels of selectin P-ligand (SELPLG), and the housekeeping gene β-actin in the vascular compartment, were assessed by two-step RRT-PCR, as described in the above section. Briefly, RRT-PCR was performed using a Power SYBR green kit (Applied Biosystems) and Fast 7500 equipment (Applied Biosystems). PCR reactions were performed as described in the above section and primer sequences and the GenBank accession number are illustrated in Additional file 1. The expression levels were normalized using the house-keeping gene β-actin using the relative standard curve method and taking into account primer efficiency. The results are expressed as arbitrary units. Primer sequences for the SELPLG gene was designed as described previously . The ferret-specific SELPLG gene is available in the NCBI nucleotide database . The amplification product was detected by electrophoresis to validate the size of the product, in accordance with the primer design, and the products were purified using a QIAquick PCR Purification Kit (Qiagen). Sequencing reactions were performed with ABI Prism BigDye Terminator Cycle Sequencing v.3.1 Ready Reaction (Applied Biosystems), and analysed using an ABI PRISM model 3730 automated sequencer (Applied Biosystems). The amplified sequence correlated with the ferret specific target sequences.
Data visualization was performed with GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA). All statistical analysis was performed using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA). For all analysis, ferret was used as the experimental unit. The significance level (α) was set at 0.05. The Shapiro–Wilk’s and the Levene test were used to evaluate the normality of the distribution of the examined quantitative variables, and the homogeneity of variances, respectively. No continuous variable that had a normal distribution was detected. Thus, a non-parametric test (Wilcoxon test) using the U Mann–Whitney test was used to compare the different values obtained for all the parameters (histopathology and viral load), between groups (control versus infected), and between different compartments of the infected group (alveolar, bronchiolar and vascular), for viral load and gene expression profiles, at all sampling times.
As expected, after infection, inflammation affected firstly the bronchioli (bronchiolitis) at 12 hpi followed by extension to surrounding alveoli (bronchointerstitial pneumonia) at 24 and 72 hpi. However, some animals developed a more extended inflammation of alveolar septa (DAD) at 24 hpi. DAD was characterised by a moderate to severe bronchiolar necrosis with lymphoplasmacytic infiltration in the lamina propria, and a variable number of macrophages and neutrophils in the lumen. Vascular and alveolar oedema was also observed accompanied by inflammatory infiltrates in alveolar and perivascular areas. The alveolar septa were also congested, and presented necrosis of type-1 pneumocytes cells accompanied by interstitial inflammatory infiltrates in the septa and lumen, mainly characterised by macrophages and neutrophils. At 72 hpi, lesions were milder than at 24 hpi and consisted of mild bronchointerstitial pneumonia.
Viral detection and quantification
Viral detection and quantification by IHC was performed in lung tissues. In general, viral antigen was observed in the nucleus of bronchial and bronchiolar epithelial and glandular cells of infected animals at 12 hpi (Figure 2).
At 24 hpi, IAV antigen was observed in the nucleus of the respiratory epithelium (bronchial, bronchiolar and alveolar), and in the nuclei and cytoplasm of macrophages. In the alveolar epithelium, positive reaction was mainly observed in type II pneumocytes, but also in type I pneumocytes (Figure 2).
Quantification of IAV positive cells in the lungs of infected animals revealed that higher numbers of positive cells were observed in bronchiolar areas at 12 hpi. Statistically, significant higher numbers of positive cells in bronchial areas were observed in comparison with alveolar areas at 12 and 72 hpi (Figure 3) (p < 0.05).
Viral RNA detection by RRT-PCR in the total lung, and in the different lung compartments, and viral titration by PFU in the total lung was performed. Control animals were negative to viral titration and to viral RNA detection in the total lung, and in the different lung compartments (Figure 3). In the total lung, higher viral RNA detection was observed at 12 and 24 hpi, and then levels decreased at 72 hpi. Viral RNA detection in the different anatomic compartments of infected animals, showed higher viral RNA levels in bronchiolar and alveolar areas at 24 hpi, followed by 12 hpi. Vascular areas showed higher levels of viral RNA in comparison to control animals, at all-time points.
Viral titration in the total lung showed higher viral titers at 12 hpi, which decreased to similar levels at 24 and 72 hpi. Viral secretion on nasal swabs was only observed in animals at 72 hpi (Figure 3).
Gene expression profiles
Higher levels of IL-6 and TNFα gene expression were observed in bronchiolar areas, in comparison with alveolar and vascular areas along the experimental period. IL-6 gene expression levels were higher at 12 hpi while the highest TNFα levels were detected at 24 hpi.
Higher IL-8, CCL3 and CCL2 gene expression levels were observed at 24 hpi. IL-8 and CCL3 were more expressed in bronchiolar areas, while CCL2 was more expressed in vascular areas. Regarding the IFN response, IFNα gene expression levels were higher in bronchiolar areas at early stages post-infection (12 dpi), while IFNγ was highly expressed also at bronchiolar areas, but in later stages of infection (24 and 72 hpi). Interestingly after bronchiolar expression, high levels of IL-6 and IFNγ were also observed in alveolar and vascular areas at 12 and 24 hpi. Besides, a higher expression of IL-8 in alveolar areas was observed at 12 hpi. With regard to PRRs expression, RIG-I gene was very highly expressed r in bronchiolar areas at 24 hpi, while no major differences in expression were observed in alveolar or vascular areas throughout infection. In contrast, TLR3 was highly expressed in all the compartments, but significantly in alveolar and vascular areas at 24 hpi.
Vascular gene expression
Vascular adhesion was evaluated by the expression of SELPLG gene in vascular areas. Infected animals showed higher levels of SELPLG gene expression when compared to control animals. SELPLG expression was upregulated throughout the infection (see Additional file 2).
Three main mechanisms are suggested to be involved in pH1N1 pathogenicity: (i) alveolar epithelial necrosis, caused by viral cytopathogenicity, and the release of cytokines by infected cells; (ii) activation of lung vasculature, which increases endothelial permeability, releases cytokines, and triggers leukocyte migration; and (iii) damage triggered by the inflammatory infiltrates, mainly formed by neutrophils and macrophages, plus the release of cytokines from these cells . These mechanisms work in a feed forward manner, eventually increasing the inflammatory damage produced.
In this study, inflammation was firstly observed in bronchiolar compartments, in association with viral replication in bronchiolar epithelial cells and the higher expression of IFNα and IL-6, early after infection. These findings were expected, since the bronchiolar epithelium is one of the first targets after IAV infection [10, 28]. Later, more severe histopathological lesions were observed in correspondence with higher presence of leukocytes and the infection of alveolar epithelial cells. Concurrently, bronchiolar areas presented the higher expression of TNFα, CCL3, IL-8 and IFNγ. Alveolar areas were also shown to contribute to the influx of inflammatory cells by the up-regulation of IFNα, IL-6 and IL-8, at 12 hpi, and CCL3 and IFNγ, at 24 hpi. The up-regulation of IL-8, IFNγ and CCL3 has been related to lung recruitment of neutrophils, NK and T cells and the development of severe influenza infection [8, 14, 19, 29]. In addition, TNFα and IL-6 up-regulation mediate phagocytic inflammatory infiltration and the apoptosis of infected cells [10, 30], which has also been associated with severe lung lesions after IAV [7, 11, 31]. Our results indicate that early infection of bronchiolar epithelial cells followed by alveolar epithelial cells are the primary source of inflammatory mediators and contribute to the severity of the lung lesion after IAV infection.
Several studies have pointed to the protective role of IFNα release after IAV and other viral infections [32–35]. Here, IFNα was highly upregulated in bronchiolar areas in association with the presence of IAV antigen detected by IHC in bronchiolar epithelial cells. In contrast, the expression of this cytokine in alveolar areas was not as relevant as in the bronchiolar compartment, even though viral replication was extensive in the alveolar compartment at 24 hpi. This differential IFNα expression observed in the lung compartments might reflect diverse intracellular signalling pathways in different cell types, with distinct physiological functions (bronchiolar epithelial cell versus pneumocyte). In that sense, the PRRs TLR3 and RIG-I were also up-regulated differently in the lung compartments studied, which may indicate that the different cell types recognise viral incursions and activate the release of cytokines through different signalling pathways.
In bronchiolar areas, the up-regulation of different immune mediators was associated to a strong up-regulation of RIG-I. RIG-I is activated by the detection of viral RNA in replication and its activation has been associated with protective and enhanced T cell responses against infection and the induction of IFN responses [8, 36].
In contrast to bronchiolar areas, vascular and alveolar areas presented a higher induction of TLR3 but did not show up-regulation of RIG-I at any time point. After IAV infection, TLR3 recognizes infected cells and induces an antiviral state that recruits damage-inducing inflammatory cells contributing to lung pathology . Different studies reported that TLR3 up-regulation was associated with a higher induction of different pro-inflammatory molecules, such as CCL2, particularly in vascular areas . The detrimental role of CCL2 in IAV pathogenesis was proven in a study where CCR2 deficient mice infected with IAV inhibited macrophage migration to the lungs, increasing survival rates [35, 37]. Other studies have also associated CCL2 upregulation with poorer outcomes of infection [10, 11, 38–40]. In our study, vascular areas showed most of CCL2 expression, particularly at 24 hpi, when leukocyte migration was most observed. In addition to CCL2, a higher up-regulation of IL-6 and IFNγ was also observed at 24 hpi in vascular areas, which expression has also been related with severe pathology after IAV infection . These data establish a link between TLR3 signalling and the activation of endothelial and alveolar epithelial cells, leading to the release of different pro-inflammatory mediators, after IAV infection. In the present study, viral active replication was not observed in vascular areas and only low viral antigen was detected by IHC in alveolar areas at early stages of infection, when TLR3 was highly upregulated. TLR3 is expressed in the endosomal compartments of various cellular types, whose activation is mediated by the recognition of double stranded RNA (dsRNA), entered into the cell by endocytosis [20, 21, 41, 42]. Since dsRNA is a universal pathogen-associated molecular pattern (PAMP), it has been assumed that TLR3 would play a key role in antiviral immunity. However, it has been demonstrated that TLR3 also contributes to pulmonary damage through the induction of pro-inflammatory molecules and the recruitment of leukocytes, during IAV virus infection [7, 42–46]. Furthermore, TLR3 polymorphisms have been shown to be related to severe cases of influenza infection in humans and mice [42, 47, 48] and its upregulation has been associated with severe pulmonary lesions in the ferret model after IAV infection [42, 46–49]. Moreover, it is known that TLR3 signalling is not required for the initial cell-autonomous recognition of viral infection or the induction of IFNα, which is induced via viral recognition by RIG-I . These data support the results observed in this study and suggests that viruses actively replicating in the cytoplasm are recognized by RIG-I, but not TLR3, irrespective of their route of entry . Besides, it has been proved that influenza virus-infected cells do not generate dsRNA , due to the activity of the cellular RNA helicase UAP56 . Therefore, we hypothesize that TLR3 may recognize unidentified RNA structures, from dying influenza virus-infected cells (cell-derived extracellular RNA or eRNA), or viral components from non-replicative viruses. Supporting this hypothesis, replication-deficient IAV, arisen from internal deletions of IAVs, significantly activated endothelial lung cells inducing a strong host cell response . Besides, it has been recently proved, in vitro and in vivo, that various types of non-self eRNA can be sensed by recipient cells during infection, inducing the release of pro-inflammatory cytokines from recipient cells [17, 53–55].
In summary, our data points to the role of the respiratory bronchiolar epithelium as the first source of pro-inflammatory cytokines and the influx of phagocytic cells into the lungs, early after IAV infection, through the activation of RIG-I. In addition, alveolar and vascular areas contributed to the induction of the pro-inflammatory innate immune response, through the activation of TLR3. In vascular areas, this activation was observed to be independent of active viral replication. We hypothesize that the innate immune response induced by vascular areas, may be consequence of signals triggered by the detection of viral RNA, or, through a complex crosstalk mechanism with the infected lung epithelium.
The authors declare that they have no competing interests.
BV, MM, JoM, JaM and NM conceived and designed the study. BV, JoM, NM, JaM, MM, LC and MP carried out sample collection and laboratorial analysis. BV, JoM and NM wrote the manuscript. All authors read and approved the final manuscript.
This work was funded by the Instituto de Salud Carlos III (“Programa especial de investigación sobre la gripe pandémica” GR09/0023, GR09/0040, GR09/0039), and the Servei de Diagnòstic de Patologia Veterinària (SDPV) of the Universitat Autònoma de Barcelona. The authors are grateful to the BSL3 facility staff for the technical support they provided during the experimental infection period.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Wong JY, Kelly H, Cheung CM, Shiu EY, Wu P, Ni MY, Ip DK, Cowling BJ (2015) Hospitalization fatality risk of influenza A(H1N1)pdm09: a systematic review and meta-analysis. Am J Epidemiol 182:294–301View ArticlePubMedPubMed CentralGoogle Scholar
- Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, California Pandemic (H1N1) Working Group (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302:1896–1902View ArticlePubMedGoogle Scholar
- Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J, Sumner J, Liu L, Patel M, Batten B, Greer P, Jones T, Smith C, Bartlett J, Montague J, White E, Rollin D, Gao R, Seales C, Jost H, Metcalfe M, Goldsmith CS, Humphrey C, Schmitz A, Drew C, Paddock C, Uyeki TM, Zaki SR (2010) 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177:166–175View ArticlePubMedPubMed CentralGoogle Scholar
- Hsieh YH, Tsai CA, Lin CY, Chen JH, King CC, Chao DY, Cheng KF (2014) Asymptomatic ratio for seasonal H1N1 influenza infection among schoolchildren in Taiwan. BMC Infect Dis 14:80View ArticlePubMedPubMed CentralGoogle Scholar
- Melchior TB, Perosa AH, Camargo CN, Granato C, Bellei N (2015) Influenza virus prevalence in asymptomatic and symptomatic subjects during pandemic and postpandemic periods. Am J Infect Control 43:460–464View ArticlePubMedGoogle Scholar
- Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF (2012) Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol 2:276–286View ArticlePubMedGoogle Scholar
- Mauad T, Hajjar LA, Callegari GD, da Silva LF, Schout D, Galas FR, Alves VA, Malheiros DM, Auler JO Jr, Ferreira AF, Borsato MR, Bezerra SM, Gutierrez PS, Caldini ET, Pasqualucci CA, Dolhnikoff M, Saldiva PH (2010) Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 181:72–79View ArticlePubMedGoogle Scholar
- Vidana B, Martinez J, Martinez-Orellana P, Garcia Migura L, Montoya M, Martorell J, Majo N (2014) Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung. Vet Res 45:85View ArticlePubMedPubMed CentralGoogle Scholar
- Brandes M, Klauschen F, Kuchen S, Germain RN (2013) A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154:197–212View ArticlePubMedPubMed CentralGoogle Scholar
- Short KR, Kroeze EJ, Fouchier RA, Kuiken T (2014) Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis 14:57–69View ArticlePubMedGoogle Scholar
- van den Brand JM, Haagmans BL, van Riel D, Osterhaus AD, Kuiken T (2014) The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 151:83–112View ArticlePubMedGoogle Scholar
- Oshansky CM, Thomas PG (2012) The human side of influenza. J Leukoc Biol 92:83–96View ArticlePubMedPubMed CentralGoogle Scholar
- Teijaro JR, Walsh KB, Rice S, Rosen H, Oldstone MB (2014) Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc Natl Acad Sci U S A 111:3799–3804View ArticlePubMedPubMed CentralGoogle Scholar
- Iwasaki A, Pillai PS (2014) Innate immunity to influenza virus infection. Nat Rev Immunol 14:315–328View ArticlePubMedPubMed CentralGoogle Scholar
- Moret I, Lorenzo MJ, Sarria B, Cases E, Morcillo E, Perpina M, Molina JM, Menendez R (2011) Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia. Eur Respir J 38:1158–1164View ArticlePubMedGoogle Scholar
- Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H (2011) Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146:980–991View ArticlePubMedPubMed CentralGoogle Scholar
- Armstrong SM, Darwish I, Lee WL (2013) Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection. Virulence 4:537–542View ArticlePubMedGoogle Scholar
- Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76:16–32View ArticlePubMedPubMed CentralGoogle Scholar
- Berri F, Le VB, Jandrot-Perrus M, Lina B, Riteau B (2014) Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits. Cell Mol Life Sci 71:885–898View ArticlePubMedGoogle Scholar
- van de Sandt CE, Kreijtz JH, Rimmelzwaan GF (2012) Evasion of influenza A viruses from innate and adaptive immune responses. Viruses 4:1438–1476View ArticlePubMedPubMed CentralGoogle Scholar
- Opitz B, van Laak V, Eitel J, Suttorp N (2010) Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 181:1294–1309View ArticlePubMedGoogle Scholar
- Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493–497Google Scholar
- Martinez-Orellana P, Martorell J, Vidana B, Majo N, Martinez J, Falcon A, Rodriguez-Frandsen A, Casas I, Pozo F, Garcia-Migura L, Garcia-Barreno B, Melero JA, Fraile L, Nieto A, Montoya M (2015) Clinical response to pandemic H1N1 influenza virus from a fatal and mild case in ferrets. Virol J 12:48View ArticlePubMedPubMed CentralGoogle Scholar
- Haines DM, Chelack BJ (1991) Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. J Vet Diagn Invest 3:101–112View ArticlePubMedGoogle Scholar
- Busquets N, Segales J, Cordoba L, Mussa T, Crisci E, Martin-Valls GE, Simon-Grife M, Perez-Simo M, Perez-Maillo M, Nunez JI, Abad FX, Fraile L, Pina S, Majo N, Bensaid A, Domingo M, Montoya M (2010) Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus. Vet Res 41:74View ArticlePubMedPubMed CentralGoogle Scholar
- Fang Y, Rowe T, Leon AJ, Banner D, Danesh A, Xu L, Ran L, Bosinger SE, Guan Y, Chen H, Cameron CC, Cameron MJ, Kelvin DJ (2010) Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus. J Virol 84:8369–8388View ArticlePubMedPubMed CentralGoogle Scholar
- NCBI. NCBI nucleotide database. https://www.ncbi.nlm.nih.gov/nuccore/JP017660.1
- Sanders CJ, Doherty PC, Thomas PG (2011) Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res 343:13–21View ArticlePubMedGoogle Scholar
- Abdul-Careem MF, Mian MF, Yue G, Gillgrass A, Chenoweth MJ, Barra NG, Chew MV, Chan T, Al-Garawi AA, Jordana M, Ashkar AA (2012) Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis 206:167–177View ArticlePubMedGoogle Scholar
- Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, Mack M, Kuziel WA, Corazza N, Brunner T, Seeger W, Lohmeyer J (2008) Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 205:3065–3077View ArticlePubMedPubMed CentralGoogle Scholar
- van den Brand JM, Stittelaar KJ, van Amerongen G, Reperant L, de Waal L, Osterhaus AD, Kuiken T (2012) Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets. PLoS One 7:e42343View ArticlePubMedPubMed CentralGoogle Scholar
- Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V (2008) Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 376:53–59View ArticlePubMedGoogle Scholar
- Beilharz MW, Cummins JM, Bennett AL (2007) Protection from lethal influenza virus challenge by oral type 1 interferon. Biochem Biophys Res Commun 355:740–744View ArticlePubMedGoogle Scholar
- Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, van Amerongen G, van Riel D, de Jong T, Itamura S, Chan KH, Tashiro M, Osterhaus AD (2004) Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 10:290–293View ArticlePubMedGoogle Scholar
- Fukuyama S, Kawaoka Y (2011) The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 23:481–486View ArticlePubMedPubMed CentralGoogle Scholar
- Kulkarni RR, Rasheed MA, Bhaumik SK, Ranjan P, Cao W, Davis C, Marisetti K, Thomas S, Gangappa S, Sambhara S, Murali-Krishna K (2014) Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity. J Virol 88:13990–14001View ArticlePubMedPubMed CentralGoogle Scholar
- Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156:1951–1959View ArticlePubMedPubMed CentralGoogle Scholar
- Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, Ngai KL, Lui GC, Wong BC, Lee SK, Choi KW, Hui DS (2011) Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 6:e26050View ArticlePubMedPubMed CentralGoogle Scholar
- Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD (2008) CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 180:2562–2572View ArticlePubMedGoogle Scholar
- Rowe T, Leon AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, Ng DC, Ran R, Weirback HK, Wiley CA, Kelvin DJ, Ross TM (2010) Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 401:257–265View ArticlePubMedPubMed CentralGoogle Scholar
- Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3. Nature 413:732–738View ArticlePubMedGoogle Scholar
- Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M (2006) Detrimental contribution of the toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2:e53View ArticlePubMedPubMed CentralGoogle Scholar
- Bradley LM, Douglass MF, Chatterjee D, Akira S, Baaten BJ (2012) Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog 8:e1002641View ArticlePubMedPubMed CentralGoogle Scholar
- Vercammen E, Staal J, Beyaert R (2008) Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 21:13–25View ArticlePubMedPubMed CentralGoogle Scholar
- Lee N, Wong CK, Hui DS, Lee SK, Wong RY, Ngai KL, Chan MC, Chu YJ, Ho AW, Lui GC, Wong BC, Wong SH, Yip SP, Chan PK (2013) Role of human toll-like receptors in naturally occurring influenza A infections. Influenza Other Respir Viruses 7:666–675View ArticlePubMedGoogle Scholar
- Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M (2005) Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 280:5571–5580View ArticlePubMedGoogle Scholar
- Esposito S, Molteni CG, Giliani S, Mazza C, Scala A, Tagliaferri L, Pelucchi C, Fossali E, Plebani A, Principi N (2012) Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children. Virol J 9:270View ArticlePubMedPubMed CentralGoogle Scholar
- Majde JA, Kapas L, Bohnet SG, De A, Krueger JM (2010) Attenuation of the influenza virus sickness behavior in mice deficient in toll-like receptor 3. Brain Behav Immun 24:306–315View ArticlePubMedGoogle Scholar
- Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB (2004) Does toll-like receptor 3 play a biological role in virus infections? Virology 322:231–238View ArticlePubMedGoogle Scholar
- Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801View ArticlePubMedGoogle Scholar
- Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, e Sousa CR (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997–1001View ArticlePubMedGoogle Scholar
- Wisskirchen C, Ludersdorfer TH, Muller DA, Moritz E, Pavlovic J (2011) The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection. J Virol 85:8646–8655View ArticlePubMedPubMed CentralGoogle Scholar
- Frensing T, Pflugmacher A, Bachmann M, Peschel B, Reichl U (2014) Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production. Appl Microbiol Biotechnol 98:8999–9008View ArticlePubMedGoogle Scholar
- Armstrong SM, Mubareka S, Lee WL (2013) The lung microvascular endothelium as a therapeutic target in severe influenza. Antiviral Res 99:113–118View ArticlePubMedGoogle Scholar
- Fischer S, Grantzow T, Pagel JI, Tschernatsch M, Sperandio M, Preissner KT, Deindl E (2012) Extracellular RNA promotes leukocyte recruitment in the vascular system by mobilising proinflammatory cytokines. Thromb Haemost 108:730–741View ArticlePubMedGoogle Scholar